528 related articles for article (PubMed ID: 10217649)
1. Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure.
Schwinger RH; Wang J; Frank K; Müller-Ehmsen J; Brixius K; McDonough AA; Erdmann E
Circulation; 1999 Apr; 99(16):2105-12. PubMed ID: 10217649
[TBL] [Abstract][Full Text] [Related]
2. Region specific regulation of sodium pump isoform and Na,Ca-exchanger expression in the failing human heart--right atrium vs left ventricle.
Müller-Ehmsen J; Wang J; Schwinger RH; McDonough AA
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):373-81. PubMed ID: 11357898
[TBL] [Abstract][Full Text] [Related]
3. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH
Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852
[TBL] [Abstract][Full Text] [Related]
4. The cardiac sodium pump: structure and function.
McDonough AA; Velotta JB; Schwinger RH; Philipson KD; Farley RA
Basic Res Cardiol; 2002; 97 Suppl 1():I19-24. PubMed ID: 12479229
[TBL] [Abstract][Full Text] [Related]
5. Regional expression of sodium pump subunits isoforms and Na+-Ca++ exchanger in the human heart.
Wang J; Schwinger RH; Frank K; Müller-Ehmsen J; Martin-Vasallo P; Pressley TA; Xiang A; Erdmann E; McDonough AA
J Clin Invest; 1996 Oct; 98(7):1650-8. PubMed ID: 8833915
[TBL] [Abstract][Full Text] [Related]
6. Enhanced sensitivity of the failing human myocardium to cardiac glycosides and Na(+)-channel activators.
Schwinger RH; Müller-Ehmsen J; Frank K; Koch A; Erdmann E
Am Heart J; 1996 May; 131(5):988-93. PubMed ID: 8615321
[TBL] [Abstract][Full Text] [Related]
7. Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium.
Flesch M; Schwinger RH; Schiffer F; Frank K; Südkamp M; Kuhn-Regnier F; Arnold G; Böhm M
Circulation; 1996 Sep; 94(5):992-1002. PubMed ID: 8790037
[TBL] [Abstract][Full Text] [Related]
8. Increased functional importance of the Na,Ca-exchanger in contracting failing human myocardium but unchanged activity in isolated vesicles.
Diedrichs H; Frank K; Schneider CA; Burst V; Hagemeister J; Zobel C; Müller-Ehmsen J
Int Heart J; 2007 Nov; 48(6):755-66. PubMed ID: 18160767
[TBL] [Abstract][Full Text] [Related]
9. Na(+)-channel activators increase cardiac glycoside sensitivity in failing human myocardium.
Schwinger RH; Böhm M; La Rosée K; Schmidt U; Schulz C; Erdmann E
J Cardiovasc Pharmacol; 1992 Apr; 19(4):554-61. PubMed ID: 1380598
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
Schwinger RH; Böhm M; Mittmann C; La Rosée K; Erdmann E
J Mol Cell Cardiol; 1991 Apr; 23(4):461-71. PubMed ID: 1658340
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium.
Schwinger RH; Müller-Ehmsen J; Böhm M; Erdmann E
J Pharmacol Exp Ther; 1996 Mar; 276(3):1180-8. PubMed ID: 8786551
[TBL] [Abstract][Full Text] [Related]
12. Preconditioning attenuates ischemia-reperfusion-induced remodeling of Na+-K+-ATPase in hearts.
Elmoselhi AB; Lukas A; Ostadal P; Dhalla NS
Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1055-63. PubMed ID: 12763751
[TBL] [Abstract][Full Text] [Related]
13. Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure.
Studer R; Reinecke H; Bilger J; Eschenhagen T; Böhm M; Hasenfuss G; Just H; Holtz J; Drexler H
Circ Res; 1994 Sep; 75(3):443-53. PubMed ID: 8062418
[TBL] [Abstract][Full Text] [Related]
14. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts.
Schwinger RH; Böhm M; Schmidt U; Karczewski P; Bavendiek U; Flesch M; Krause EG; Erdmann E
Circulation; 1995 Dec; 92(11):3220-8. PubMed ID: 7586307
[TBL] [Abstract][Full Text] [Related]
15. Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium.
Müller-Ehmsen J; Brixius K; Schwinger RH
J Cardiovasc Pharmacol; 1998 May; 31(5):684-9. PubMed ID: 9593067
[TBL] [Abstract][Full Text] [Related]
16. Low-dose ouabain administration increases Na⁺,K⁺-ATPase activity and reduces cardiac force development in rats.
Meira EF; Siman FD; Faria Tde O; Júnior RF; de Batista PR; Stefanon I; Vassallo DV; Padilha AS
Pharmacol Rep; 2015 Apr; 67(2):253-9. PubMed ID: 25712647
[TBL] [Abstract][Full Text] [Related]
17. Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts.
Schwinger RH; Hoischen S; Reuter H; Hullin R
J Mol Cell Cardiol; 1999 Jan; 31(1):283-96. PubMed ID: 10072735
[TBL] [Abstract][Full Text] [Related]
18. Na+/K+ ATPase and its functional coupling with Na+/Ca2+ exchanger in mouse embryonic stem cells during differentiation into cardiomyocytes.
Otsu K; Kuruma A; Yanagida E; Shoji S; Inoue T; Hirayama Y; Uematsu H; Hara Y; Kawano S
Cell Calcium; 2005 Feb; 37(2):137-51. PubMed ID: 15589994
[TBL] [Abstract][Full Text] [Related]
19. Isoform-specific regulation of myocardial Na,K-ATPase alpha-subunit in congestive heart failure. Role of norepinephrine.
Kim CH; Fan TH; Kelly PF; Himura Y; Delehanty JM; Hang CL; Liang CS
Circulation; 1994 Jan; 89(1):313-20. PubMed ID: 8281663
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Na+/Ca2+ exchange activity in patients with end-stage heart failure.
Reinecke H; Studer R; Vetter R; Holtz J; Drexler H
Cardiovasc Res; 1996 Jan; 31(1):48-54. PubMed ID: 8849588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
